These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Dengue fever: from disease to vaccination]. Teyssou R Med Trop (Mars); 2009 Aug; 69(4):333-4. PubMed ID: 19725380 [TBL] [Abstract][Full Text] [Related]
4. [Dengue: a growing risk to travellers to tropical and sub-tropical regions]. da Silva-Voorham JM; Tami A; Juliana AE; Rodenhuis-Zybert IA; Wilschut JC; Smit JM Ned Tijdschr Geneeskd; 2009; 153():A778. PubMed ID: 20025792 [TBL] [Abstract][Full Text] [Related]
5. [Dengue as haemorrhagic fever]. Olszyńska-Krowicka M Przegl Epidemiol; 2011; 65(4):567-9. PubMed ID: 22390040 [TBL] [Abstract][Full Text] [Related]
6. Review of dengue virus and the development of a vaccine. Murrell S; Wu SC; Butler M Biotechnol Adv; 2011; 29(2):239-47. PubMed ID: 21146601 [TBL] [Abstract][Full Text] [Related]
7. Understanding dengue pathogenesis: implications for vaccine design. Stephenson JR Bull World Health Organ; 2005 Apr; 83(4):308-14. PubMed ID: 15868023 [TBL] [Abstract][Full Text] [Related]
8. Dengue and yellow fever--challenges for the development and use of vaccines. Monath TP N Engl J Med; 2007 Nov; 357(22):2222-5. PubMed ID: 18046026 [No Abstract] [Full Text] [Related]
9. Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children. Simasathien S; Thomas SJ; Watanaveeradej V; Nisalak A; Barberousse C; Innis BL; Sun W; Putnak JR; Eckels KH; Hutagalung Y; Gibbons RV; Zhang C; De La Barrera R; Jarman RG; Chawachalasai W; Mammen MP Am J Trop Med Hyg; 2008 Mar; 78(3):426-33. PubMed ID: 18337339 [TBL] [Abstract][Full Text] [Related]
11. Progress for dengue virus diseases. Towards the NS2B-NS3pro inhibition for a therapeutic-based approach. Melino S; Paci M FEBS J; 2007 Jun; 274(12):2986-3002. PubMed ID: 17509079 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of a live attenuated tetravalent candidate dengue vaccine in naïve and previously infected cynomolgus macaques. Koraka P; Benton S; van Amerongen G; Stittelaar KJ; Osterhaus AD Vaccine; 2007 Jul; 25(29):5409-16. PubMed ID: 17560694 [TBL] [Abstract][Full Text] [Related]
13. Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses. Guy B; Guirakhoo F; Barban V; Higgs S; Monath TP; Lang J Vaccine; 2010 Jan; 28(3):632-49. PubMed ID: 19808029 [TBL] [Abstract][Full Text] [Related]
14. Dengue fever in the Western Hemisphere. Castleberry JS; Mahon CR Clin Lab Sci; 2003; 16(1):34-8. PubMed ID: 12587656 [TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of sanofi pasteur tetravalent dengue vaccine. Guy B J Clin Virol; 2009 Oct; 46 Suppl 2():S16-9. PubMed ID: 19800561 [TBL] [Abstract][Full Text] [Related]
17. [Emergence of dengue hemorrhagic fever in the Americas. Reemergence of dengue]. Guzmán Tirado MG; Kourí Flores G; Bravo González JR Rev Cubana Med Trop; 1999; 51(1):5-13. PubMed ID: 10887549 [TBL] [Abstract][Full Text] [Related]
18. Climatic factors associated with epidemic dengue in Palembang, Indonesia: implications of short-term meteorological events on virus transmission. Bangs MJ; Larasati RP; Corwin AL; Wuryadi S Southeast Asian J Trop Med Public Health; 2006 Nov; 37(6):1103-16. PubMed ID: 17333762 [TBL] [Abstract][Full Text] [Related]
20. Low oral receptivity for dengue type 2 viruses of Aedes albopictus from Southeast Asia compared with that of Aedes aegypti. Vazeille M; Rosen L; Mousson L; Failloux AB Am J Trop Med Hyg; 2003 Feb; 68(2):203-8. PubMed ID: 12641412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]